Premium
Short‐ and long‐term clinical outcome after various stent implantation: Overview of the results of uni‐ and multicenter stent registries
Author(s) -
Gyöngyösi Mariann,
Khorsand Aliashgar,
Sperker Wolfgang,
Strehblow Christoph,
Wexberg Paul,
Probst Peter,
Siostrzonek Peter,
Lang Irene,
Sochor Heinz,
Glogar Dietmar
Publication year - 2004
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.20013
Subject(s) - mace , medicine , stent , restenosis , target lesion , cutoff , drug eluting stent , radiology , cardiology , surgery , percutaneous coronary intervention , myocardial infarction , physics , quantum mechanics
Abstract The present study reports the results of the short‐ and long‐term outcomes of prospective uni‐ and multicenter stent registries: Palmaz‐Schatz (n = 140 patients), Ave‐Micro and GFX (n = 280), Multilink Duet (n = 340), Multilink Tetra (n = 192), and Carbo (n = 140) Stent Registries, as well as the predictors and angiographic cutoff points predicting major adverse cardiac events (MACE) after different stent implantations. Significant decrease in subacute stent thrombosis (from 2.9% to 0) and MACE (from 35% to 8.3%) occurred as the improved stents, optimized stent implantation technique, and new postintervention drug therapy were introduced. The changes of angiographic cutoff values (postintervention minimal lumen diameter and preintervention reference diameter: from 2.9 and 3.1 mm for Palmaz‐Schatz to 2.5 and 2.8 mm for Multilink Duet, Multilink Tetra, and Carbo stents) and clinical and angiographic factors predicting MACE indicated the change of traditional restenosis paradigm and that progress in clinical practice might be able to counterbalance unfavorable lesion and intervention‐related characteristics. Catheter Cardiovasc Interv 2004;62:331–338. © 2004 Wiley‐Liss, Inc.